As of Jul 24
| +0.11 / +0.51%|
The 6 analysts offering 12-month price forecasts for PTC Therapeutics Inc have a median target of 19.00, with a high estimate of 25.00 and a low estimate of 12.00. The median estimate represents a -11.83% decrease from the last price of 21.55.
The current consensus among 7 polled investment analysts is to Hold stock in PTC Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.